nodes	percent_of_prediction	percent_of_DWPC	metapath
Mepivacaine—Cranial nerve paralysis—Methotrexate—testicular cancer	0.0567	0.0567	CcSEcCtD
Mepivacaine—Meningism—Methotrexate—testicular cancer	0.0377	0.0377	CcSEcCtD
Mepivacaine—Acidosis—Ifosfamide—testicular cancer	0.0249	0.0249	CcSEcCtD
Mepivacaine—Ventricular arrhythmia—Ifosfamide—testicular cancer	0.0187	0.0187	CcSEcCtD
Mepivacaine—Urinary incontinence—Ifosfamide—testicular cancer	0.0133	0.0133	CcSEcCtD
Mepivacaine—Apnoea—Etoposide—testicular cancer	0.0129	0.0129	CcSEcCtD
Mepivacaine—Body temperature increased—Carboplatin—testicular cancer	0.0114	0.0114	CcSEcCtD
Mepivacaine—Swelling—Ifosfamide—testicular cancer	0.0114	0.0114	CcSEcCtD
Mepivacaine—Cardiac arrest—Ifosfamide—testicular cancer	0.00953	0.00953	CcSEcCtD
Mepivacaine—Urinary retention—Ifosfamide—testicular cancer	0.00953	0.00953	CcSEcCtD
Mepivacaine—Paralysis—Methotrexate—testicular cancer	0.0094	0.0094	CcSEcCtD
Mepivacaine—Swelling—Etoposide—testicular cancer	0.00898	0.00898	CcSEcCtD
Mepivacaine—Anaphylactoid reaction—Cisplatin—testicular cancer	0.00893	0.00893	CcSEcCtD
Mepivacaine—Paralysis—Epirubicin—testicular cancer	0.0088	0.0088	CcSEcCtD
Mepivacaine—Tremor—Chlorambucil—testicular cancer	0.00855	0.00855	CcSEcCtD
Mepivacaine—Agitation—Chlorambucil—testicular cancer	0.00839	0.00839	CcSEcCtD
Mepivacaine—Angioedema—Chlorambucil—testicular cancer	0.00834	0.00834	CcSEcCtD
Mepivacaine—Ventricular arrhythmia—Epirubicin—testicular cancer	0.00826	0.00826	CcSEcCtD
Mepivacaine—Anaphylactoid reaction—Etoposide—testicular cancer	0.00818	0.00818	CcSEcCtD
Mepivacaine—Paralysis—Doxorubicin—testicular cancer	0.00814	0.00814	CcSEcCtD
Mepivacaine—Convulsion—Chlorambucil—testicular cancer	0.00791	0.00791	CcSEcCtD
Mepivacaine—Apnoea—Methotrexate—testicular cancer	0.00771	0.00771	CcSEcCtD
Mepivacaine—Ventricular arrhythmia—Doxorubicin—testicular cancer	0.00764	0.00764	CcSEcCtD
Mepivacaine—Cardiac arrest—Etoposide—testicular cancer	0.00753	0.00753	CcSEcCtD
Mepivacaine—Chills—Bleomycin—testicular cancer	0.00728	0.00728	CcSEcCtD
Mepivacaine—Sweating increased—Cisplatin—testicular cancer	0.00728	0.00728	CcSEcCtD
Mepivacaine—Convulsion—Vinblastine—testicular cancer	0.00725	0.00725	CcSEcCtD
Mepivacaine—Hypertension—Vinblastine—testicular cancer	0.00722	0.00722	CcSEcCtD
Mepivacaine—Erythema—Bleomycin—testicular cancer	0.00706	0.00706	CcSEcCtD
Mepivacaine—Bradycardia—Ifosfamide—testicular cancer	0.00706	0.00706	CcSEcCtD
Mepivacaine—Chills—Dactinomycin—testicular cancer	0.00679	0.00679	CcSEcCtD
Mepivacaine—Sweating increased—Etoposide—testicular cancer	0.00667	0.00667	CcSEcCtD
Mepivacaine—Erythema—Dactinomycin—testicular cancer	0.00659	0.00659	CcSEcCtD
Mepivacaine—Tinnitus—Ifosfamide—testicular cancer	0.00647	0.00647	CcSEcCtD
Mepivacaine—Atrioventricular block—Epirubicin—testicular cancer	0.0063	0.0063	CcSEcCtD
Mepivacaine—Chills—Ifosfamide—testicular cancer	0.00622	0.00622	CcSEcCtD
Mepivacaine—Paraesthesia—Vinblastine—testicular cancer	0.00613	0.00613	CcSEcCtD
Mepivacaine—Bradycardia—Cisplatin—testicular cancer	0.00609	0.00609	CcSEcCtD
Mepivacaine—Erythema—Ifosfamide—testicular cancer	0.00604	0.00604	CcSEcCtD
Mepivacaine—Urticaria—Chlorambucil—testicular cancer	0.00592	0.00592	CcSEcCtD
Mepivacaine—Body temperature increased—Chlorambucil—testicular cancer	0.00589	0.00589	CcSEcCtD
Mepivacaine—Atrioventricular block—Doxorubicin—testicular cancer	0.00583	0.00583	CcSEcCtD
Mepivacaine—Anaphylactic shock—Bleomycin—testicular cancer	0.00577	0.00577	CcSEcCtD
Mepivacaine—Oedema—Bleomycin—testicular cancer	0.00577	0.00577	CcSEcCtD
Mepivacaine—Vision blurred—Ifosfamide—testicular cancer	0.00569	0.00569	CcSEcCtD
Mepivacaine—Tinnitus—Cisplatin—testicular cancer	0.00557	0.00557	CcSEcCtD
Mepivacaine—Agitation—Ifosfamide—testicular cancer	0.00555	0.00555	CcSEcCtD
Mepivacaine—Angioedema—Ifosfamide—testicular cancer	0.00552	0.00552	CcSEcCtD
Mepivacaine—Hypersensitivity—Chlorambucil—testicular cancer	0.00549	0.00549	CcSEcCtD
Mepivacaine—Hypotension—Bleomycin—testicular cancer	0.00539	0.00539	CcSEcCtD
Mepivacaine—Oedema—Dactinomycin—testicular cancer	0.00538	0.00538	CcSEcCtD
Mepivacaine—Asthenia—Chlorambucil—testicular cancer	0.00534	0.00534	CcSEcCtD
Mepivacaine—Pruritus—Chlorambucil—testicular cancer	0.00527	0.00527	CcSEcCtD
Mepivacaine—Convulsion—Ifosfamide—testicular cancer	0.00523	0.00523	CcSEcCtD
Mepivacaine—Hypertension—Ifosfamide—testicular cancer	0.00521	0.00521	CcSEcCtD
Mepivacaine—Erythema—Cisplatin—testicular cancer	0.00521	0.00521	CcSEcCtD
Mepivacaine—Paraesthesia—Bleomycin—testicular cancer	0.00518	0.00518	CcSEcCtD
Mepivacaine—Hypersensitivity—Vinblastine—testicular cancer	0.00503	0.00503	CcSEcCtD
Mepivacaine—Anaphylactic shock—Ifosfamide—testicular cancer	0.00493	0.00493	CcSEcCtD
Mepivacaine—Oedema—Ifosfamide—testicular cancer	0.00493	0.00493	CcSEcCtD
Mepivacaine—Chills—Etoposide—testicular cancer	0.00492	0.00492	CcSEcCtD
Mepivacaine—Vision blurred—Cisplatin—testicular cancer	0.00491	0.00491	CcSEcCtD
Mepivacaine—Anaphylactoid reaction—Methotrexate—testicular cancer	0.0049	0.0049	CcSEcCtD
Mepivacaine—Asthenia—Vinblastine—testicular cancer	0.0049	0.0049	CcSEcCtD
Mepivacaine—Tremor—Cisplatin—testicular cancer	0.00488	0.00488	CcSEcCtD
Mepivacaine—Hyperhidrosis—Ifosfamide—testicular cancer	0.00476	0.00476	CcSEcCtD
Mepivacaine—Vomiting—Chlorambucil—testicular cancer	0.00474	0.00474	CcSEcCtD
Mepivacaine—Back pain—Etoposide—testicular cancer	0.00461	0.00461	CcSEcCtD
Mepivacaine—Hypotension—Ifosfamide—testicular cancer	0.0046	0.0046	CcSEcCtD
Mepivacaine—Anaphylactoid reaction—Epirubicin—testicular cancer	0.00459	0.00459	CcSEcCtD
Mepivacaine—Urticaria—Bleomycin—testicular cancer	0.00458	0.00458	CcSEcCtD
Mepivacaine—Body temperature increased—Bleomycin—testicular cancer	0.00456	0.00456	CcSEcCtD
Mepivacaine—Dizziness—Vinblastine—testicular cancer	0.00451	0.00451	CcSEcCtD
Mepivacaine—Convulsion—Cisplatin—testicular cancer	0.00451	0.00451	CcSEcCtD
Mepivacaine—Nausea—Chlorambucil—testicular cancer	0.00442	0.00442	CcSEcCtD
Mepivacaine—Paraesthesia—Ifosfamide—testicular cancer	0.00442	0.00442	CcSEcCtD
Mepivacaine—Anxiety—Cisplatin—testicular cancer	0.00442	0.00442	CcSEcCtD
Mepivacaine—Somnolence—Ifosfamide—testicular cancer	0.00438	0.00438	CcSEcCtD
Mepivacaine—Vomiting—Vinblastine—testicular cancer	0.00434	0.00434	CcSEcCtD
Mepivacaine—Headache—Vinblastine—testicular cancer	0.00428	0.00428	CcSEcCtD
Mepivacaine—Body temperature increased—Dactinomycin—testicular cancer	0.00425	0.00425	CcSEcCtD
Mepivacaine—Oedema—Cisplatin—testicular cancer	0.00425	0.00425	CcSEcCtD
Mepivacaine—Anaphylactic shock—Cisplatin—testicular cancer	0.00425	0.00425	CcSEcCtD
Mepivacaine—Hypersensitivity—Bleomycin—testicular cancer	0.00425	0.00425	CcSEcCtD
Mepivacaine—Anaphylactoid reaction—Doxorubicin—testicular cancer	0.00424	0.00424	CcSEcCtD
Mepivacaine—Cardiac arrest—Epirubicin—testicular cancer	0.00422	0.00422	CcSEcCtD
Mepivacaine—Loss of consciousness—Etoposide—testicular cancer	0.00419	0.00419	CcSEcCtD
Mepivacaine—Tachycardia—Cisplatin—testicular cancer	0.00415	0.00415	CcSEcCtD
Mepivacaine—Asthenia—Bleomycin—testicular cancer	0.00414	0.00414	CcSEcCtD
Mepivacaine—Convulsion—Etoposide—testicular cancer	0.00413	0.00413	CcSEcCtD
Mepivacaine—Hypertension—Etoposide—testicular cancer	0.00412	0.00412	CcSEcCtD
Mepivacaine—Hyperhidrosis—Cisplatin—testicular cancer	0.00411	0.00411	CcSEcCtD
Mepivacaine—Pruritus—Bleomycin—testicular cancer	0.00408	0.00408	CcSEcCtD
Mepivacaine—Nausea—Vinblastine—testicular cancer	0.00405	0.00405	CcSEcCtD
Mepivacaine—Hypotension—Cisplatin—testicular cancer	0.00397	0.00397	CcSEcCtD
Mepivacaine—Hypersensitivity—Dactinomycin—testicular cancer	0.00396	0.00396	CcSEcCtD
Mepivacaine—Urticaria—Ifosfamide—testicular cancer	0.00391	0.00391	CcSEcCtD
Mepivacaine—Cardiac arrest—Doxorubicin—testicular cancer	0.00391	0.00391	CcSEcCtD
Mepivacaine—Body temperature increased—Ifosfamide—testicular cancer	0.0039	0.0039	CcSEcCtD
Mepivacaine—Anaphylactic shock—Etoposide—testicular cancer	0.00389	0.00389	CcSEcCtD
Mepivacaine—Asthenia—Dactinomycin—testicular cancer	0.00386	0.00386	CcSEcCtD
Mepivacaine—Paraesthesia—Cisplatin—testicular cancer	0.00381	0.00381	CcSEcCtD
Mepivacaine—Tachycardia—Etoposide—testicular cancer	0.0038	0.0038	CcSEcCtD
Mepivacaine—Hyperhidrosis—Etoposide—testicular cancer	0.00376	0.00376	CcSEcCtD
Mepivacaine—Vomiting—Bleomycin—testicular cancer	0.00367	0.00367	CcSEcCtD
Mepivacaine—Drowsiness—Methotrexate—testicular cancer	0.00366	0.00366	CcSEcCtD
Mepivacaine—Hypotension—Etoposide—testicular cancer	0.00364	0.00364	CcSEcCtD
Mepivacaine—Hypersensitivity—Ifosfamide—testicular cancer	0.00363	0.00363	CcSEcCtD
Mepivacaine—Asthenia—Ifosfamide—testicular cancer	0.00354	0.00354	CcSEcCtD
Mepivacaine—Sweating—Methotrexate—testicular cancer	0.0035	0.0035	CcSEcCtD
Mepivacaine—Paraesthesia—Etoposide—testicular cancer	0.00349	0.00349	CcSEcCtD
Mepivacaine—Pruritus—Ifosfamide—testicular cancer	0.00349	0.00349	CcSEcCtD
Mepivacaine—Somnolence—Etoposide—testicular cancer	0.00346	0.00346	CcSEcCtD
Mepivacaine—Nausea—Bleomycin—testicular cancer	0.00342	0.00342	CcSEcCtD
Mepivacaine—Drowsiness—Epirubicin—testicular cancer	0.00342	0.00342	CcSEcCtD
Mepivacaine—Vomiting—Dactinomycin—testicular cancer	0.00342	0.00342	CcSEcCtD
Mepivacaine—Body temperature increased—Cisplatin—testicular cancer	0.00336	0.00336	CcSEcCtD
Mepivacaine—Sweating—Epirubicin—testicular cancer	0.00328	0.00328	CcSEcCtD
Mepivacaine—Dizziness—Ifosfamide—testicular cancer	0.00326	0.00326	CcSEcCtD
Mepivacaine—Nausea—Dactinomycin—testicular cancer	0.00319	0.00319	CcSEcCtD
Mepivacaine—Drowsiness—Doxorubicin—testicular cancer	0.00316	0.00316	CcSEcCtD
Mepivacaine—Vomiting—Ifosfamide—testicular cancer	0.00313	0.00313	CcSEcCtD
Mepivacaine—Hypersensitivity—Cisplatin—testicular cancer	0.00313	0.00313	CcSEcCtD
Mepivacaine—Bradycardia—Epirubicin—testicular cancer	0.00313	0.00313	CcSEcCtD
Mepivacaine—Urticaria—Etoposide—testicular cancer	0.00309	0.00309	CcSEcCtD
Mepivacaine—Body temperature increased—Etoposide—testicular cancer	0.00308	0.00308	CcSEcCtD
Mepivacaine—Tinnitus—Methotrexate—testicular cancer	0.00306	0.00306	CcSEcCtD
Mepivacaine—Asthenia—Cisplatin—testicular cancer	0.00305	0.00305	CcSEcCtD
Mepivacaine—Sweating—Doxorubicin—testicular cancer	0.00303	0.00303	CcSEcCtD
Mepivacaine—Chills—Methotrexate—testicular cancer	0.00294	0.00294	CcSEcCtD
Mepivacaine—Nausea—Ifosfamide—testicular cancer	0.00293	0.00293	CcSEcCtD
Mepivacaine—Bradycardia—Doxorubicin—testicular cancer	0.00289	0.00289	CcSEcCtD
Mepivacaine—Hypersensitivity—Etoposide—testicular cancer	0.00287	0.00287	CcSEcCtD
Mepivacaine—Tinnitus—Epirubicin—testicular cancer	0.00286	0.00286	CcSEcCtD
Mepivacaine—Erythema—Methotrexate—testicular cancer	0.00286	0.00286	CcSEcCtD
Mepivacaine—Asthenia—Etoposide—testicular cancer	0.00279	0.00279	CcSEcCtD
Mepivacaine—Back pain—Methotrexate—testicular cancer	0.00276	0.00276	CcSEcCtD
Mepivacaine—Chills—Epirubicin—testicular cancer	0.00276	0.00276	CcSEcCtD
Mepivacaine—Pruritus—Etoposide—testicular cancer	0.00275	0.00275	CcSEcCtD
Mepivacaine—Vomiting—Cisplatin—testicular cancer	0.0027	0.0027	CcSEcCtD
Mepivacaine—Vision blurred—Methotrexate—testicular cancer	0.00269	0.00269	CcSEcCtD
Mepivacaine—Erythema—Epirubicin—testicular cancer	0.00267	0.00267	CcSEcCtD
Mepivacaine—Tinnitus—Doxorubicin—testicular cancer	0.00265	0.00265	CcSEcCtD
Mepivacaine—Tension—Epirubicin—testicular cancer	0.00262	0.00262	CcSEcCtD
Mepivacaine—Nervousness—Epirubicin—testicular cancer	0.0026	0.0026	CcSEcCtD
Mepivacaine—Back pain—Epirubicin—testicular cancer	0.00259	0.00259	CcSEcCtD
Mepivacaine—Dizziness—Etoposide—testicular cancer	0.00257	0.00257	CcSEcCtD
Mepivacaine—Chills—Doxorubicin—testicular cancer	0.00255	0.00255	CcSEcCtD
Mepivacaine—Nausea—Cisplatin—testicular cancer	0.00252	0.00252	CcSEcCtD
Mepivacaine—Vision blurred—Epirubicin—testicular cancer	0.00252	0.00252	CcSEcCtD
Mepivacaine—Convulsion—Methotrexate—testicular cancer	0.00247	0.00247	CcSEcCtD
Mepivacaine—Vomiting—Etoposide—testicular cancer	0.00247	0.00247	CcSEcCtD
Mepivacaine—Erythema—Doxorubicin—testicular cancer	0.00247	0.00247	CcSEcCtD
Mepivacaine—Agitation—Epirubicin—testicular cancer	0.00246	0.00246	CcSEcCtD
Mepivacaine—Headache—Etoposide—testicular cancer	0.00244	0.00244	CcSEcCtD
Mepivacaine—Tension—Doxorubicin—testicular cancer	0.00243	0.00243	CcSEcCtD
Mepivacaine—Nervousness—Doxorubicin—testicular cancer	0.0024	0.0024	CcSEcCtD
Mepivacaine—Syncope—Epirubicin—testicular cancer	0.0024	0.0024	CcSEcCtD
Mepivacaine—Back pain—Doxorubicin—testicular cancer	0.00239	0.00239	CcSEcCtD
Mepivacaine—Loss of consciousness—Epirubicin—testicular cancer	0.00235	0.00235	CcSEcCtD
Mepivacaine—Anaphylactic shock—Methotrexate—testicular cancer	0.00233	0.00233	CcSEcCtD
Mepivacaine—Vision blurred—Doxorubicin—testicular cancer	0.00233	0.00233	CcSEcCtD
Mepivacaine—Convulsion—Epirubicin—testicular cancer	0.00232	0.00232	CcSEcCtD
Mepivacaine—Nausea—Etoposide—testicular cancer	0.00231	0.00231	CcSEcCtD
Mepivacaine—Hypertension—Epirubicin—testicular cancer	0.00231	0.00231	CcSEcCtD
Mepivacaine—Agitation—Doxorubicin—testicular cancer	0.00227	0.00227	CcSEcCtD
Mepivacaine—Anxiety—Epirubicin—testicular cancer	0.00227	0.00227	CcSEcCtD
Mepivacaine—Hyperhidrosis—Methotrexate—testicular cancer	0.00225	0.00225	CcSEcCtD
Mepivacaine—Syncope—Doxorubicin—testicular cancer	0.00222	0.00222	CcSEcCtD
Mepivacaine—Anaphylactic shock—Epirubicin—testicular cancer	0.00218	0.00218	CcSEcCtD
Mepivacaine—Oedema—Epirubicin—testicular cancer	0.00218	0.00218	CcSEcCtD
Mepivacaine—Hypotension—Methotrexate—testicular cancer	0.00218	0.00218	CcSEcCtD
Mepivacaine—Loss of consciousness—Doxorubicin—testicular cancer	0.00217	0.00217	CcSEcCtD
Mepivacaine—Shock—Epirubicin—testicular cancer	0.00215	0.00215	CcSEcCtD
Mepivacaine—Convulsion—Doxorubicin—testicular cancer	0.00214	0.00214	CcSEcCtD
Mepivacaine—Hypertension—Doxorubicin—testicular cancer	0.00214	0.00214	CcSEcCtD
Mepivacaine—Tachycardia—Epirubicin—testicular cancer	0.00213	0.00213	CcSEcCtD
Mepivacaine—Hyperhidrosis—Epirubicin—testicular cancer	0.00211	0.00211	CcSEcCtD
Mepivacaine—Anxiety—Doxorubicin—testicular cancer	0.0021	0.0021	CcSEcCtD
Mepivacaine—Paraesthesia—Methotrexate—testicular cancer	0.00209	0.00209	CcSEcCtD
Mepivacaine—Somnolence—Methotrexate—testicular cancer	0.00207	0.00207	CcSEcCtD
Mepivacaine—Hypotension—Epirubicin—testicular cancer	0.00204	0.00204	CcSEcCtD
Mepivacaine—Anaphylactic shock—Doxorubicin—testicular cancer	0.00202	0.00202	CcSEcCtD
Mepivacaine—Oedema—Doxorubicin—testicular cancer	0.00202	0.00202	CcSEcCtD
Mepivacaine—Shock—Doxorubicin—testicular cancer	0.00199	0.00199	CcSEcCtD
Mepivacaine—Tachycardia—Doxorubicin—testicular cancer	0.00197	0.00197	CcSEcCtD
Mepivacaine—Paraesthesia—Epirubicin—testicular cancer	0.00196	0.00196	CcSEcCtD
Mepivacaine—Hyperhidrosis—Doxorubicin—testicular cancer	0.00195	0.00195	CcSEcCtD
Mepivacaine—Somnolence—Epirubicin—testicular cancer	0.00194	0.00194	CcSEcCtD
Mepivacaine—Hypotension—Doxorubicin—testicular cancer	0.00189	0.00189	CcSEcCtD
Mepivacaine—Urticaria—Methotrexate—testicular cancer	0.00185	0.00185	CcSEcCtD
Mepivacaine—Body temperature increased—Methotrexate—testicular cancer	0.00184	0.00184	CcSEcCtD
Mepivacaine—Paraesthesia—Doxorubicin—testicular cancer	0.00181	0.00181	CcSEcCtD
Mepivacaine—Somnolence—Doxorubicin—testicular cancer	0.00179	0.00179	CcSEcCtD
Mepivacaine—Urticaria—Epirubicin—testicular cancer	0.00173	0.00173	CcSEcCtD
Mepivacaine—Body temperature increased—Epirubicin—testicular cancer	0.00172	0.00172	CcSEcCtD
Mepivacaine—Hypersensitivity—Methotrexate—testicular cancer	0.00172	0.00172	CcSEcCtD
Mepivacaine—Asthenia—Methotrexate—testicular cancer	0.00167	0.00167	CcSEcCtD
Mepivacaine—Pruritus—Methotrexate—testicular cancer	0.00165	0.00165	CcSEcCtD
Mepivacaine—Hypersensitivity—Epirubicin—testicular cancer	0.00161	0.00161	CcSEcCtD
Mepivacaine—Urticaria—Doxorubicin—testicular cancer	0.0016	0.0016	CcSEcCtD
Mepivacaine—Body temperature increased—Doxorubicin—testicular cancer	0.0016	0.0016	CcSEcCtD
Mepivacaine—Asthenia—Epirubicin—testicular cancer	0.00157	0.00157	CcSEcCtD
Mepivacaine—Pruritus—Epirubicin—testicular cancer	0.00154	0.00154	CcSEcCtD
Mepivacaine—Dizziness—Methotrexate—testicular cancer	0.00154	0.00154	CcSEcCtD
Mepivacaine—Hypersensitivity—Doxorubicin—testicular cancer	0.00149	0.00149	CcSEcCtD
Mepivacaine—Vomiting—Methotrexate—testicular cancer	0.00148	0.00148	CcSEcCtD
Mepivacaine—Headache—Methotrexate—testicular cancer	0.00146	0.00146	CcSEcCtD
Mepivacaine—Asthenia—Doxorubicin—testicular cancer	0.00145	0.00145	CcSEcCtD
Mepivacaine—Dizziness—Epirubicin—testicular cancer	0.00144	0.00144	CcSEcCtD
Mepivacaine—Pruritus—Doxorubicin—testicular cancer	0.00143	0.00143	CcSEcCtD
Mepivacaine—Vomiting—Epirubicin—testicular cancer	0.00139	0.00139	CcSEcCtD
Mepivacaine—Nausea—Methotrexate—testicular cancer	0.00138	0.00138	CcSEcCtD
Mepivacaine—Headache—Epirubicin—testicular cancer	0.00137	0.00137	CcSEcCtD
Mepivacaine—Dizziness—Doxorubicin—testicular cancer	0.00133	0.00133	CcSEcCtD
Mepivacaine—Nausea—Epirubicin—testicular cancer	0.0013	0.0013	CcSEcCtD
Mepivacaine—Vomiting—Doxorubicin—testicular cancer	0.00128	0.00128	CcSEcCtD
Mepivacaine—Headache—Doxorubicin—testicular cancer	0.00126	0.00126	CcSEcCtD
Mepivacaine—Nausea—Doxorubicin—testicular cancer	0.0012	0.0012	CcSEcCtD
